NUEDEXTA - 64597-301-60 - (dextromethorphan hydrobromide and quinidine sulfate)

Alphabetical Index


Drug Information of NUEDEXTA

Product NDC: 64597-301
Proprietary Name: NUEDEXTA
Non Proprietary Name: dextromethorphan hydrobromide and quinidine sulfate
Active Ingredient(s): 20; 10    mg/1; mg/1 & nbsp;   dextromethorphan hydrobromide and quinidine sulfate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of NUEDEXTA

Product NDC: 64597-301
Labeler Name: Avanir Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021879
Marketing Category: NDA
Start Marketing Date: 20101201

Package Information of NUEDEXTA

Package NDC: 64597-301-60
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE (64597-301-60)

NDC Information of NUEDEXTA

NDC Code 64597-301-60
Proprietary Name NUEDEXTA
Package Description 60 CAPSULE, GELATIN COATED in 1 BOTTLE (64597-301-60)
Product NDC 64597-301
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name dextromethorphan hydrobromide and quinidine sulfate
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 20101201
Marketing Category Name NDA
Labeler Name Avanir Pharmaceuticals, Inc.
Substance Name DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
Strength Number 20; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA]

Complete Information of NUEDEXTA


General Information